NCT07472322 2026-03-16
ASTX727 & Retifanlimab-dlwr for Advanced Merkel Cell After Progression on Anti-PD-(L)1
University of Wisconsin, Madison
Phase 1/2 Not yet recruiting
University of Wisconsin, Madison
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano